IIM
ABBV icon

INTECH Investment Management’s AbbVie ABBV Stock Holding History

INTECH Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8M Sell
49,673
-18,393
-27% -$4.08M 0.11% 163
2025
Q4 		$15.6M Sell
68,066
-2,467
-3% -$562K 0.14% 121
2025
Q3 		$16.3M Sell
70,533
-25,923
-27% -$5.28M 0.15% 108
2025
Q2 		$17.9M Sell
96,456
-31,239
-24% -$5.81M 0.17% 84
2025
Q1 		$26.8M Sell
127,695
-90,154
-41% -$17.5M 0.28% 51
2024
Q4 		$38.7M Buy
217,849
+15,976
+8% +$2.94M 0.38% 41
2024
Q3 		$39.9M Sell
201,873
-78,974
-28% -$14.7M 0.45% 33
2024
Q2 		$48.2M Sell
280,847
-19,657
-7% -$3.26M 0.6% 23
2024
Q1 		$54.7M Sell
300,504
-293,747
-49% -$50.6M 0.77% 19
2023
Q4 		$92.1M Buy
594,251
+59,718
+11% +$8.71M 1.34% 10
2023
Q3 		$79.7M Sell
534,533
-284,800
-35% -$41.8M 1.18% 13
2023
Q2 		$110M Sell
819,333
-201,127
-20% -$29.5M 1.14% 9
2023
Q1 		$163M Buy
1,020,460
+117,721
+13% +$18M 1.31% 5
2022
Q4 		$146M Sell
902,739
-57,397
-6% -$8.8M 1.09% 9
2022
Q3 		$129M Buy
960,136
+38,109
+4% +$5.47M 0.97% 14
2022
Q2 		$141M Buy
+922,027
New +$141M 0.81% 18

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

INTECH Investment Management's ABBV Position: Q1 2026 in Review

INTECH Investment Management reduced its AbbVie (ABBV) stake by 27% in Q1 2026, selling an estimated $4.08M and leaving 49,673 shares worth $10.8M. The position accounts for 0.11% of the portfolio, ranked #163.

INTECH Investment Management first reported a position in ABBV in Q2 2022 and has held it in 16 quarters since. The position peaked at $163M in Q1 2023. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • INTECH Investment Management held 49,673 shares of AbbVie worth $10.8M as of Q1 2026.
  • INTECH Investment Management sold 18,393 AbbVie shares in Q1 2026, an estimated $4.08M.
  • AbbVie made up 0.11% of INTECH Investment Management's portfolio in Q1 2026, its #163 holding.
  • INTECH Investment Management first reported a position in AbbVie in Q2 2022 and has held it in 16 quarters since.
  • INTECH Investment Management's AbbVie position peaked at $163M in Q1 2023.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.